Results 91 to 100 of about 2,687 (162)

Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art. [PDF]

EJNMMI Radiopharm Chem
Paraïso P, van Deurzen CHM, Seimbille Y.   +2 more
europepmc   +1 more source

Diagnostic performance of gastrin-releasing peptide receptor-targeted positron-emission tomography in biochemically recurrent prostate cancer-a systematic review and meta-analysis. [PDF]

Quant Imaging Med Surg
Huang H, Huang Y, Xie Z, Tian R, Shen G.
europepmc   +1 more source

The role of naturally-occurring canine tumors in translating conserved consequences of epithelial-mesenchymal plasticity to human cancers. [PDF]

Front Vet Sci
Bakhle KM, Dongre A.
europepmc   +1 more source

Biodistribution of the Bombesin Receptor-Targeted Radiopharmaceutical Precursor BBN/C1-C2 in a Prostate Cancer Model. [PDF]

Sovrem Tekhnologii Med
Beloborodov EA, Iurova EV, Dolgova DR, Ermakova AA, Sugak DE, Fomin AN, Saenko YV.   +6 more
europepmc   +1 more source

Butylated Neuropeptide Antagonist Targeting Hypoxia-Induced GRPR Overexpression in Small Cell Lung Cancer. [PDF]

Int J Mol Sci
Deureh S, Alghamdi AM, Latif A, Williams KJ, Gieling RG, Aojula HS.   +5 more
europepmc   +1 more source

Will GRPR Compete with PSMA as a Target in Prostate Cancer? [PDF]

Journal of Nuclear Medicine, 2017
openaire   +2 more sources

Phase 1 Study of [¹⁷⁷Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results. [PDF]

J Nucl Med
Mittra ES, Solnes LB, van der Veldt AAM, Wong J, Aloj L, Heinrich MC, Chen CT, Rowe SP, Brabander T, Pacey S, Aimone P, Pathak D, Blumenstein L, Liu Y, Iagaru A.   +14 more
europepmc   +1 more source

Down-regulation of gastrin-releasing peptide in medial orbitofrontal cortex to nucleus accumbens projections contributes to allodynia and negative affect. [PDF]

Sci Adv
Zhao T, Chen A, Dai D, Li Z, Feng E, Gao XF, Xiong L.   +6 more
europepmc   +1 more source

Phase I Clinical Study with the GRPR-Antagonist [^99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference? [PDF]

Pharmaceutics
Orlova A, Rybina A, Medvedeva A, Zelchan R, Bragina O, Tashireva L, Larkina M, Varvashenya R, Lushnikova N, Kanellopoulos P, Maina T, Nock BA, Tolmachev V, Chernov V.   +13 more
europepmc   +1 more source

A true theranostic pair - ^44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer. [PDF]

Eur J Nucl Med Mol Imaging
Kumar N, Bilinska A, Menéndez E, Läppchen T, Moon ES, Zoltowska M, Pawlak D, Cieszykowska I, Mikolajczak R, Rösch F, Rominger A, Gourni E.   +11 more
europepmc   +1 more source